Best Life Sciences Companies in Netanya, Israel
The 48 best Life Sciences companies in Netanya, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ART Medical.
Our analysis of 50 Life Sciences companies
$2.2b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Netanya
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ART Medical Developer of product for ICU based safe enteral nourishment | $27M | 110 mo ago | Series B | Ori Braun Chief Executive Officer | 2009 | WordPressMySQLPHP+32 | 112 patents Advanced enteral nutrition delivery and monitoring technologies for patient-specific feeding control | 1 job opening |
| 2 | NovoGI Compression anastomosis devices for GI disease management | $18M | 204 mo ago | Deadpooled | — | 1996 | — | 5 patents Patents concentrated in health & consumer products | — |
| 3 | BioGenCell Developer of stem cell therapies for blood vessel diseases | $17M | 51 mo ago | Seed | Michael Belkin Co-Founder | 2008 | — | 19 patents Stem cell isolation devices and directed activation/differentiation methods for regenerative therapies | — |
| 4 | Angioslide Embolic capture device integrated with angioplasty balloon to prevent distal embolization | $15M | 163 mo ago | Series B | — | 2005 | — | 82 patents Balloon catheters for vascular drug delivery and interventional therapy | — |
| 5 | HeraMED Developer of remote maternity monitoring platform and related smart devices | $7M | 31 mo ago | Public | — | 2011 | WixSentryBootstrap+13 | — | 2 launchs · 1 award |
| 6 | JaxBio Developer of an AI-based chip for genetic and epigenetic profiling | $6M | 24 mo ago | Seed | Dror Feldheim Co-Founder | 2020 | — | — | — |
| 7 | Trobix Bio Developer of microbiome-based therapeutics that address various therapeutic areas | $6M | 40 mo ago | Series A | — | 2018 | — | — | — |
| 8 | Hairstetics Multiple hair implantation device | $2M | 170 mo ago | Seed | Boaz Shenhav Co-Founder & CEO | 2010 | — | 25 patents Hair implantation anchors and devices for surgical hair restoration procedures. | — |
| 9 | Pro IV Infusion & transfusion management systems | $2M | 211 mo ago | Funding Raised | Michal Devir Co-Founder | 2006 | — | 17 patents Patents concentrated in computing, sensing & instrumentation | — |
| 10 | Limaca Medical Developing endoscopic ultrasound fine needle biopsy system | $1M | 69 mo ago | Seed | Assaf Klein CEO | 2017 | — | 25 patents Percutaneous biopsy instruments for tissue penetration, separation, and sampling | 2 job openings · 1 partnership |
| 11 | DentaRay CO2 based laser for surgical, aesthetics & dental applications | $600K | 217 mo ago | Seed | — | 2008 | — | 12 patents Patents concentrated in electrical & electronics | — |
Top 12 Life Sciences companies in Netanya
#1
Seed · Netanya, Central District · founded 2020$6Mraised▾
Developer of an AI-based chip for genetic and epigenetic profiling. It offers a set of biomarkers that assists with the identification of different kinds of cancer. It has features for diagnostic tests with a multi-cancer approach system. The chip can be used for detecting genetic and epigenetic profiles
- Jul 2024Grant (prize money)$2.7M
- Jan 2023Grant (prize money)$9.1M
- Jan 2023Grant (prize money)$1.9M
- 2022Seed$6M
#2
Public · Netanya, Central District · founded 2011 · 21 employees$6.7Mraised▾
Developer of remote maternity monitoring platform and related smart devices. The platform offers customizable care plans, telehealth video and chat, and smart messaging. It provides remote patient monitoring, educational content, and prenatal and postpartum care. The platform aims to streamline care delivery and facilitate real-time patient health monitoring. It captures vitals, prioritizes out-of-range measurements, and manages patient adherence through a care management dashboard.
- Dec 2023Post IPO$1.2M
- Aug 2022Post IPO$4M
- Dec 2019Post IPO$1.4M
#3
Series A · Netanya, Central District · founded 2018 · 9 employees$6Mraised▾
Developer of microbiome-based therapeutics that address various therapeutic areas. The company is leveraging TBX technology that combines proprietary molecular engineering and computational algorithms tools to develop CRISPR-based synthetic phages for precision delivery of DNA payloads to target bacteria. It has developed a pipeline for oncology indications and gut inflammatory disorders.
- Mar 2023Series A$3M
- Jul 2020Series A$3M
#4
Seed · Netanya, Central District · founded 2008 · 13 employees$17Mraised▾
Developer of stem cell therapies for blood vessel diseases. Its proprietary technology platform provides a comprehensive solution for cellular therapy, supporting scalable, automated manufacturing from both fresh and bio-banked tissues. Its lead product BGC101 is manufactured from stem cells and culture components extracted from the patient’s own blood for blood vessel regeneration.
- May 2022Seed$16M
- Nov 2009Seed$1M
- Grant (prize money)$250K
#5
Series B · Netanya, Central District · founded 2009 · 18 employees$27Mraised▾
ART Healthcare is focussed on developing emergency solutions for safe enteral nourishment. It has developed a nasogastric tube along with a console- patent-pending technology for supervised enteral feeding with physiological monitoring. Its products named smARTrack System & smART system are in the development stage and have applications in the real-time prevention of aspiration pneumonia in enterally fed patients. It also offered FDA approved devices for ICU like ventilator-associated pneumonia (VAP), malnutrition, and acute kidney injury (AKI) among others.
- Jun 2017Series B$20M
- Series A$7M
#6
Series B · Netanya, Central District · founded 2005 · 12 employees$14.6Mraised▾
Angioslide has developed the Proteus device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Distal embolization is a common complication of interventions to treat PAD. Angioslide helps physicians to manage embolic load released during procedures . The device enables physicians to capture and remove embolic particles dislodged at the lesion site in peripheral arteries through the device's Proteus Embolic capture feature which is integrated with the balloon. PROTEUS embolic capture feature involves a single-use suction mechanism that works through inward folding of the balloon, which creates negative pressure within the capture cavity for debris capture and removal. The reduced pressure in the capture cavity causes some of the particles that are released during the procedure to flow into the cavity for containment and removal. Used during angioplasty procedures. Product is both FDA and CE cleared for use in the lower limbs i.e. the femoral, iliac, ilio-femoral, popliteal, tibial, peroneal and profunda arteries.
- Jan 2013Series B$6.3M
- Oct 2009Series B$8.2M
#7
Deadpooled · Netanya, Central District · founded 1996 · 47 employees$18.5Mraised▾
NovoGI, formerly NiTi Surgical Solutions, provides medical devices for GI disease management. Offers nitinol-based compression anastomosis devices for treating patients undergoing colorectal resection procedures. CE-marked and FDA-cleared surgical devices. Its R&D, and manufacturing facilities are in Netanya, Israel and the US headquarter is in Atlanta, Georgia, and European headquarters are in Paris, and France.
#8
Seed · Netanya, Central District · founded 2017 · 5 employees$1.2Mraised▾
Limaca Medical is an early stage company developing an endoscopic ultrasound fine needle biopsy system. As of Apr 2017, the product is in the technology development stage and the company is operating from Trendlines. It hasn't disclosed the product information and development details.
- Nov 2020Seed$1.2M
#9
Seed · Netanya, Central District · founded 2010 · 12 employees$1.5Mraised▾
Developer of multiple-hair implantation device intended to help people with hair fall problems. The company's product aims to simplify the implantation procedure, shorten recovery time and provide superior aesthetic results at a lower cost than traditional methods, enabling customers with innovative hair loss treatment options.
#10
Funding Raised · Netanya, Central District · founded 2006$1.5Mraised▾
Pro-IV is focussed on developing a system for the monitoring, managing and preventing of errors in infusion and transfusion. Its system called IMMAGINE ( Intravenous Monitoring, MAnaGemeNt and Error-prevention) system enhances a high degree of error prevention in the IV infusion of drugs and blood transfusions; improves the bedside management of patients receiving IV drug therapy or blood transfusions & improves the accuracy, monitoring, and documenting of electronic patient data. As of September 2016, the product is in clinical development.
- Dec 2008Grant (prize money)$1.5M
#11
Seed · Netanya, Central District · founded 2008 · 3 employees$600Kraised▾
DentaRay is focussed on developing a CO2 laser technology for use in surgical, aesthetic and dental applications. Its first flagship product called DentaRay 9600 is a CO2 based laser for tissue dental applications that can be used at high settings for cutting and vaporizing & low settings for melting hard tissue. As of October 2016, the product is in beta stage development.
- Jul 2008Seed$600K
#12
Funding Raised · Netanya, Central District · founded 2011 · 6 employees—raised▾
Manufacturer of bi-component hemostatic and sealing products designed to control severe bleeding and seal leakages during and post-surgery. The company's products consist of a polymeric film with a biological sealant and include fibrin sealant, enabling doctors to control hemorrhages in cases of first aid, trauma care, and surgery.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Israel
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.
- Ministry of Agriculture118
- Hebrew University of Jerusalem29
- Agricultural Research Organization25
- Tel Aviv University21
- Ben-Gurion University of the Negev19
- Mitochondrion1→5
- Gene1→18
- Plant disease resistance1→7
- Resistance (ecology)2→6
- Agriculture3→6
Where biotechnology is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.